Proteasome Inhibitors: Beyond NFKB Inhibition Alone and the Emerging Role of Combination Therapy in the Treatment of Multiple Myeloma. Hematol Meeting Rep 2009, 2 (5). https://doi.org/10.4081/hmr.v2i5.753.